Managing dyslipidaemia in young adults

Abstract

Indians have early onset atherosclerotic cardiovascular disease and acquire the risk factors at a younger age, and hence we need to aggressively address the management of dyslipidemia in the young. Cholesterol levels early in life will influence the development of atherosclerosis. Young atherosclerotic cardiovascular disease (ASCVD) patients (18–40 yrs) should receive lipid-lowering drugs to reduce LDL-C160 mg or a high coronary calcium score. Young adults who are carriers of FH gene should receive aggressive lifestyle modification and appropriate antilipidemic therapy.

Keywords

• Dyslipidemia
• ASCVD
• Young adults